- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
Eli Lilly
Market Cap: €670.6b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLYD
€634.10
7D
-2.7%
1Y
n/a
Inovio Pharmaceuticals
Market Cap: US$128.1m
A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.
0A43
US$2.39
7D
5.9%
1Y
-57.0%
Danaher
Market Cap: US$135.8b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
0R2B
US$186.99
7D
-4.3%
1Y
-30.1%
Alnylam Pharmaceuticals
Market Cap: US$59.6b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
0HD2
US$458.60
7D
-0.5%
1Y
69.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVIE
€59.48
7D
0%
1Y
n/a
Grifols
Market Cap: €7.4b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRFE
€12.22
7D
1.4%
1Y
28.2%
Oncopeptides
Market Cap: SEK 1.0b
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
0RN4
SEK 4.63
7D
-9.3%
1Y
112.2%
Madrigal Pharmaceuticals
Market Cap: US$9.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
0JXI
US$441.21
7D
4.8%
1Y
101.6%
Atara Biotherapeutics
Market Cap: US$91.1m
Engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom.
0HIY
US$13.75
7D
19.6%
1Y
88.7%
Basilea Pharmaceutica
Market Cap: CHF 568.3m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLNz
CHF 46.15
7D
0.7%
1Y
-2.7%
Swedencare
Market Cap: SEK 5.4b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
0ABG
SEK 33.55
7D
-15.3%
1Y
-21.1%
Siegfried Holding
Market Cap: CHF 3.5b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
SFZNZ
CHF 80.30
7D
-7.3%
1Y
-29.7%
Qiagen
Market Cap: €9.8b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QIAD
€38.84
7D
1.4%
1Y
-6.3%
BioNTech
Market Cap: €24.0b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
22UAD
€84.30
7D
0.5%
1Y
n/a
Equillium
Market Cap: US$85.7m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
0A4D
US$1.49
7D
-3.3%
1Y
73.7%